Showing results (71-80 of 95) with videos related to
Sort By:
Pageof 10
Cancer Immunology Research|September 15, 2017
Extracellular S100A9 Protein in Bone Marrow Supports Multiple Myeloma Survival by Stimulating Angiogenesis and Cytokine SecretionKim De Veirman, Nathan De Beule, Ken Maes, et al.The American Journal of Pathology|August 28, 2004
Multifunctional role of matrix metalloproteinases in multiple myeloma: a study in the 5T2MM mouse modelEls Van Valckenborgh, Peter I Croucher, Hendrik De Raeve, et al.Clinical Epigenetics|September 17, 2021
Targeting the methyltransferase SETD8 impairs tumor cell survival and overcomes drug resistance independently of p53 status in multiple myelomaLaurie Herviou, Sara Ovejero, Fanny Izard, et al.Oncotarget|April 15, 2015
Multiple myeloma induces Mcl-1 expression and survival of myeloid-derived suppressor cellsKim De Veirman, Jo A Van Ginderachter, Susanne Lub, et al.Molecular Oncology|September 11, 2025
PYCR1 inhibition in bone marrow stromal cells enhances bortezomib sensitivity in multiple myeloma cells by altering their metabolismInge Oudaert, Lauren van den Broecke, Osman Aksoy, et al.Plos One|June 7, 2013
Preclinical evaluation of invariant natural killer T cells in the 5T33 multiple myeloma modelHaneen Nur, Karel Fostier, Sandrine Aspeslagh, et al.Cancer Letters|November 13, 2018
Myeloid-derived suppressor cells induce multiple myeloma cell survival by activating the AMPK pathwayKim De Veirman, Eline Menu, Ken Maes, et al.Oncotarget|July 11, 2014
The IGF-1 receptor inhibitor picropodophyllin potentiates the anti-myeloma activity of a BH3-mimeticLiesbeth Bieghs, Susanne Lub, Karel Fostier, et al.Neurourology and Urodynamics|April 8, 2024
Transition in enuresis patients: Identifying the gaps and opportunities for the futureSevasti Karamaria, Reiner Mauel, Mauro Van den Ende, et al.Journal of Experimental & Clinical Cancer Research : CR|April 16, 2025
The de novo DNA methyltransferase 3B is a novel epigenetic regulator of MYC in multiple myeloma, representing a promising therapeutic target to counter relapseCatharina Muylaert, Lien Ann Van Hemelrijck, Arne Van der Vreken, et al.Pageof 10